---
figid: PMC7748218__nihms-1526951-f0006
figtitle: 'Model showing contribution of CXCR6-CXCL16 axis in overcoming the effect
  of DTX:'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- Phellodendron amurense
pmcid: PMC7748218
filename: nihms-1526951-f0006.jpg
figlink: pmc/articles/PMC7748218/figure/F6/
number: F6
caption: In response to DTX, prostate cancer cells up-regulate CXCR6, CXCL16 and ADAM-10,
  which also promotes CXCL16 cleavage. These changes together hyper-activate CXCR6-CXCL16
  axis. TNFα, which could be regulated by ADAM-10 and CXCL16, leads to NF-κB activation
  by TRAFs (TNF-receptor associated factors) and NIK (NF-κB-inducing kinase). NIK
  also activates IKKα and Erk1/2. Activation of IKK complex leads to phosphorylation
  of IκB and enhances its proteasomal degradation. Free NF-κB subunits are then phosphorylated
  and translocate to the nucleus where they form homo- or heterodimers and increase
  cxcr6, cxcl16, and adam-10. Hyper-activated CXCR6-CXCL16 signaling a) supports epithelial
  to mesenchymal transition via Wnt/βcatenin pathway by affecting GSK3β activation
  and β-catenin stability and b) decreases apoptosis and enhances proliferation by
  affecting ERK1/2 activation, processing and trans-activation of NFκB resulting in
  over-expression of survivin as well as other anti-apoptotic and pro-survival molecules
  in concert with Stat3.
papertitle: Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16
  to overcome effect of docetaxel.
reftext: Neeraj Kapur, et al. Cancer Lett. ;454:1-13.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9680113
figid_alias: PMC7748218__F6
figtype: Figure
organisms_ner:
- Mus musculus
- Bos taurus
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC7748218__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7748218__nihms-1526951-f0006.html
  '@type': Dataset
  description: In response to DTX, prostate cancer cells up-regulate CXCR6, CXCL16
    and ADAM-10, which also promotes CXCL16 cleavage. These changes together hyper-activate
    CXCR6-CXCL16 axis. TNFα, which could be regulated by ADAM-10 and CXCL16, leads
    to NF-κB activation by TRAFs (TNF-receptor associated factors) and NIK (NF-κB-inducing
    kinase). NIK also activates IKKα and Erk1/2. Activation of IKK complex leads to
    phosphorylation of IκB and enhances its proteasomal degradation. Free NF-κB subunits
    are then phosphorylated and translocate to the nucleus where they form homo- or
    heterodimers and increase cxcr6, cxcl16, and adam-10. Hyper-activated CXCR6-CXCL16
    signaling a) supports epithelial to mesenchymal transition via Wnt/βcatenin pathway
    by affecting GSK3β activation and β-catenin stability and b) decreases apoptosis
    and enhances proliferation by affecting ERK1/2 activation, processing and trans-activation
    of NFκB resulting in over-expression of survivin as well as other anti-apoptotic
    and pro-survival molecules in concert with Stat3.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cxcl16
  - Cxcr6
  - Adam10
  - Chuk
  - Ikbkg
  - Map4k4
  - Map3k14
  - Tnf
  - Gsk3b
  - Ikbkb
  - Csnk2a1
  - Csnk2a2
  - Mapk3
  - Mapk1
  - Nfkbib
  - Ctnnb1
  - Nfkb1
  - Bad
  - Jun
  - Hif1a
  - Cdc37
  - Lsp1
  - Pold2
  - Cd40
  - Dctn2
  - Stat3
  - Fos
  - Vegfa
  - Tgfb1
  - Egf
  - Myc
  - Nol3
  - Impact
  - CXCL16
  - CXCR6
  - ADAM10
  - TNF
  - GSK3B
  - MAPK3
  - MAPK1
  - CTNNB1
  - BAD
  - HIF1A
  - STAT3
  - JUN
  - FOS
  - VEGFA
  - TGFB1
  - EGF
  - MYC
  - IMPACT
  - Csnk2b
  - Wnt2
  - Rela
  - CHUK
  - IKBKG
  - MAP3K14
  - MAP4K4
  - IKBKB
  - CSNK2A1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - FOSB
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - CHMP2A
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - DTX
  - cytotoxicity
---
